Unstable angina: The case for selective aggression

British Journal of Cardiology

Volumn 9, Issue 5, 2002, Pages

  Smith, Elliot J ^a   Fath Ordoubadi, Farzin ^a   Curzen, Nicholas P ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOCHEMICAL MARKER; CLOPIDOGREL; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; LOW MOLECULAR WEIGHT HEPARIN; TIROFIBAN; TROPONIN;

ACUTE HEART INFARCTION; ANGIOGRAPHY; ATHEROSCLEROTIC PLAQUE; BIOCHEMISTRY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY THROMBOSIS; EDITORIAL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; RISK ASSESSMENT; ST SEGMENT DEPRESSION; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 0036571631     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (21)

1. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK)
2. Organisation to Assess Strategies for Ischaemic Syndromes (OASIS) Registry Investigators. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation
3. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group
4. Low-molecular-weight heparins in non-ST-segment elevation ischemia: The ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in Non-Q-wave Coronary Events
5. Low-molecular-weight heparin (Fragmin) during instability in coronary artery disease (FRISC). FRISC Study Group
6. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
7. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
8. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease
9. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction
10. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina
11. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia
12. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators
13. Outcome at one year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease
14. TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy) - Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
15. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. Thrombolysis in Myocardial Infarction
16. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris
17. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability
18. Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina
19. Role of platelet glycoprotein PI(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty
20. PIA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement
21. Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the PI(A2)allele of the platelet glycoprotein IIIa gene